StonvexLoading…
StonvexStonvexStonvexCore line items from ELUT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $12.29M | $14.47M | $24.75M | $23.85M |
Operating Income | $-26.91M | $-30.71M | $-30.53M | $-35.19M |
Net Income | $53.38M | $-53.95M | $-37.66M | $-32.90M |
EPS (Diluted) | $0.87 | $-1.86 | $-2.07 | $-2.38 |
Total Assets | $62.35M | $36.13M | $43.43M | $68.84M |
Total Liabilities | $34.68M | $82.39M | $82.03M | $73.87M |
Cash & Equivalents | $36.35M | $13.24M | $19.28M | $16.99M |
Free Cash Flow OCF − CapEx | $-46.69M | $-23.31M | $-22.11M | $-21.97M |
Shares Outstanding | 45.94M | 29.07M | 18.16M | 13.83M |